Preclinical Testing
Experienced veterinarians and highly equipped modern lab facilities for ex-vivo and in vivo testing of generic pharma,
new APIs, vaccines and natural actives. We offer services in variety of animal species and tissue models.
new APIs, vaccines and natural actives. We offer services in variety of animal species and tissue models.
Assessment of lead drug candidates or novel formulation safety profiles is perhaps the most important, critical and costly stage of the drug development pathway. High-quality data and rapid turnaround time are key in lead drug selection and life cycle management programs. Our aim is to design smart preclinical regulatory compliant studies and clinical research protocols to fasten this process thereby reducing the total R & D cost and time.
The complementary expertise of Re8 facilitates preclinical testing with a special focus on generic pharma, new APIs, vaccines and natural active substances. To smooth the path to market, our strong network of state-of-the-art laboratories, skilled veterinarians and pathologists are happy to support you on customized preclinical studies and related bioanalysis.
The complementary expertise of Re8 facilitates preclinical testing with a special focus on generic pharma, new APIs, vaccines and natural active substances. To smooth the path to market, our strong network of state-of-the-art laboratories, skilled veterinarians and pathologists are happy to support you on customized preclinical studies and related bioanalysis.
Our preclinical service program includes assessment of drug metabolism-pharmacokinetics (DMPK), efficacy studies, tissue distribution, absorption, distribution, metabolism, and excretion (ADME) profiles, disease transplantation models and drug safety-toxicology studies (acute/short term/long term). Re8 preclinical services can also be combined with cellular and biochemical assays to understand the full spectrum performance of drug candidates or nano/formulation.
Immunogenicity/ADA, biomarkers, mutagenicity, reproductive effects, and in vitro toxicity are additional services that can be used for this purpose. Other related services like bioanalytical testing, routine analytical services, stability, formulation development, and technology transfer are accessible under one umbrella.
Immunogenicity/ADA, biomarkers, mutagenicity, reproductive effects, and in vitro toxicity are additional services that can be used for this purpose. Other related services like bioanalytical testing, routine analytical services, stability, formulation development, and technology transfer are accessible under one umbrella.
Our Services
Pharmacokinetic
Biodistribution
Toxicology
Genotoxicity
Disease Models
Device Compatibility
Cell Line Testing
Microbial Testing
Pathology
- Drug Metabolism and Pharmacokinetic (DMPK)
- Maximum tolerable dose determination
- Absorption, distribution, metabolism, and excretion (ADME) profiles
- Selective tissue distribution studies
- Inhalation toxicity studies
- Toxicity testing
– Acute
– Sub-Acute
– Sub-Chronic
– Chronic
– Organ-specific - Disease model development
- Biocompatibility studies
- Drug-device ex-vivo and in-vivo testing
- Pathology services
– Histopathology
– Immunohistopathology
– Clinical
– Hematological - Permitted Daily Exposure (PDE) analysis
- Occupational Exposure Level (OEL) of chemicals
- Biological tissue or fluid supply
- Medical devices
We provide services to companies worldwide, faster, flexible and customized.
Share with us what you are looking for
Share with us what you are looking for
Intellectual Property
IP rights stays with you, although we contribute to your success.
You remain sole owner of IP rights.
You remain sole owner of IP rights.
Your Molecule
Our Preclinical Expertise
